In a landmark decision, the Rhode Island House has voted to legalize kratom, the herbal supplement with opioid-like effects, while imposing an age limit of 21 for its purchase. This move signals a shift in the state’s regulatory approach towards substances that have been mired in controversy.
Supporters of the bill argue that kratom could serve as a less addictive alternative to conventional opioids, potentially offering pain relief with a lower risk of dependency. On the other hand, skeptics call attention to the need for more comprehensive research into the herb’s safety and efficacy.
The passage of this bill by the House represents a nuanced stance on drug policy, favoring regulated access over outright prohibition. It’s a development that could set a precedent for how similar substances are treated legislatively in the future.
For an in-depth look at the proceedings, read the full article on The Providence Journal.